GE HealthCare PDx CEO Kevin Michael O'Neill Disposes 718 Shares for Tax Withholding
GE HealthCare Technologies Inc.
Subscribe to track GEHC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
šØ Form 4 Alert: GE HealthCare Technologies Inc. ($GEHC)
š¤ Insider: O'Neill Kevin Michael (CEO, PDx)
š
Transaction Date: 2026-09-03
š Transaction: Tax Withholding (Code F)
š Shares: 718 @ $70.56 ($50,662.08)
š Shares Retained: 32,026 direct (59 indirect)
Comprehensive Analysis
Insider Transaction Summary
- Insider: Kevin Michael O'Neill, CEO of Pharmaceutical Diagnostics (PDx) at GE HealthCare Technologies Inc. ($GEHC)
- Transaction Date: September 3, 2026
- Transaction Code:
F(Payment of exercise price or tax liability by delivering or withholding securities) - Shares Disposed: 718 shares of Common Stock at a price of $70.56 per share, totaling approximately $50,662.08.
- Direct Beneficial Ownership Post-Transaction: 32,026 shares (with an additional 59 shares held indirectly via a share incentive plan trust).
Analysis
This transaction represents a routine disposition of shares to satisfy statutory tax withholding requirements upon the vesting of restricted stock units (RSUs). It does not reflect a discretionary open-market sale or a shift in the executive's investment outlook on the company.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.